Morphine

Clinical Trials

View More Clinical Trials

Sign in to access the complete clinical trial database with detailed study information.

Title	Posted	Study ID	Phase	Status	Sponsor
Morphine or Ketamine for Analgesia	2025/02/19	NCT06835504	Phase 3	Not yet recruiting	Columbia University
Intravenous Methadone Versus Intrathecal Morphine for Analgesia Following Cesarean Delivery	2025/02/14	NCT06826742	Phase 4	Recruiting	Mayo Clinic
Analgesic Efficacy of Multiple Mid-Transverse Process to Pleura (MTP) Block and PCA in Idiopathic Scoliosis Patients Undergoing Posterior Spinal Fusion	2025/02/11	NCT06820190	Not Applicable	Completed	Tanta University
Efficacy and Safety of Intrathecal Morphine for Postoperative Pain Management Following Planned Caesarean Section	2025/01/29	2024-518678-16-00	Phase 4	Recruiting	Anne Juul Wikkelsø
Intrathecal Hydromorphone vs Intrathecal Morphine to Treat Post Cesarean Pain in Patients With Opioid Use Disorder Taking Buprenorphine	2025/01/20	NCT06784180	Phase 4	Recruiting	University of North Carolina, Chapel Hill
Intrathecal Morphine Injection Versus Continuous Wound Infiltration After Pancreaticoduodenectomy	2025/01/07	NCT06761989	Not Applicable	Recruiting	Seoul National University Hospital
Intravenous Methadone for Sternotomy Pain Control in Cardiac Surgery	2024/12/11	NCT06728371	Phase 3	Recruiting	Chinese University of Hong Kong
Effect of Propofol Administration Time on the Incidence and Severity of Intrathecal Morphine-induced Pruritus in Parturient Undergoing Elective Cesarean Delivaries	2024/12/04	NCT06715657	Phase 4	Not yet recruiting	Assiut University
Effectiveness of Adding Morphine to Intraosseous Vancomycin for Pain Control in Total Knee Arthroplasty	2024/12/04	NCT06716749	Phase 2	Recruiting	Carilion Clinic
Role of Prophylactic Antiemetics in Women Receiving Intrathecal Morphine and Lipophilic Opioids Added to Bupivacaine for Cesarean Section	2024/11/25	NCT06704139	Phase 4	Not yet recruiting	Assiut University

FDA Drug Approvals

View More FDA Approvals

Sign in to access additional FDA-approved drug information with detailed regulatory data.

Approved Product	Manufacturer	NDC Code	Route	Strength	Effective Date
AVINZA	STAT RX USA LLC	16590-597	ORAL	90 mg in 1 1	9/22/2011
Morphine sulfate	Sun Pharmaceutical Industries, Inc.	63304-450	ORAL	15 mg in 1 1	12/14/2023
MS Contin	Purdue Pharma LP	59011-261	ORAL	30 mg in 1 1	3/23/2017
Morphine Sulfate	Upsher-Smith Laboratories, LLC	0832-0228	ORAL	50 mg in 1 1	2/29/2024
Morphine Sulfate	Fresenius Kabi USA, LLC	63323-455	INTRAVENOUS, INTRAMUSCULAR	5 mg in 1 mL	12/30/2019
Morphine Sulfate	Hikma Pharmaceuticals USA Inc.	0054-0517	ORAL	100 mg in 5 mL	11/15/2024
Morphine Sulfate	Bryant Ranch Prepack	63629-2301	ORAL	20 mg in 1 mL	1/6/2022
Morphine Sulfate	Padagis US LLC	0574-7114	RECTAL	20 mg in 1 1	7/8/2019
MORPHINE SULFATE	Ascend Laboratories, LLC	67877-671	ORAL	30 mg in 1 1	8/18/2021
MS Contin	Rhodes Pharmaceuticals L.P.	42858-631	ORAL	30 mg in 1 1	12/27/2023

EMA Drug Approvals

View More EMA Approvals

Sign in to access additional EMA-approved drug information with detailed regulatory data.

Approved Product	Authorization Holder	Status	Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

View More HSA Approvals

Sign in to access additional HSA-approved drug information with detailed regulatory data.

Approved Product	Manufacturer	Approval Number	Dosage Form	Strength	Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

View More NMPA Approvals

Sign in to access additional NMPA-approved drug information with detailed regulatory data.

Approved Product	Company	Approval Number	Drug Type	Dosage Form	Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

View More PPB Approvals

Sign in to access additional PPB-approved drug information with detailed regulatory data.

Approved Product	Registration No.	Company	Licence No.	Strength	Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

View More TGA Approvals

Sign in to access additional TGA-approved drug information with detailed regulatory data.

Approved Product	ARTG ID	Sponsor	Registration Type	Status	Registration Date
ASTRAZENECA MORPHINE SULFATE 10mg/1mL injection ampoule	12431	Phebra Pty Ltd	Medicine	A	8/13/1991
DBL MORPHINE SULFATE 10mg/1mL injection ampoule	101240	Pfizer Australia Pty Ltd	Medicine	A	7/21/2004
MORPHINE LUPIN MR morphine sulfate pentahydrate 10 mg modified release tablet blister pack	225429	Southern Cross Pharma Pty Ltd	Medicine	A	7/3/2015
MORPHINE LUPIN MR morphine sulfate pentahydrate 30 mg modified release tablet blister pack	225430	Southern Cross Pharma Pty Ltd	Medicine	A	7/3/2015
SEVREDOL morphine sulfate pentahydrate 20mg tablet blister pack	214089	Mundipharma Pty Ltd	Medicine	A	10/8/2013
DEPODUR morphine sulfate pentahydrate 10 mg/1 mL suspension for injection vial	123620	Aspen Pharmacare Australia Pty Ltd	Medicine	A	10/3/2007
SEVREDOL morphine sulfate10mg tablet blister pack	47543	Mundipharma Pty Ltd	Medicine	A	4/12/1994
MORPHINE SULFATE 15 mg/1 mL MEDSURGE morphine sulfate pentahydrate 15 mg/1 mL solution for injection ampoule	308715	Medsurge Pharma Pty Ltd	Medicine	A	7/9/2019
MORPHINE SULFATE 5 mg/1 mL MEDSURGE morphine sulfate pentahydrate 5 mg/1 mL solution for injection ampoule	308714	Medsurge Pharma Pty Ltd	Medicine	A	7/9/2019
KADIAN MORPHINE SULFATE 10 mg capsule - sustained release bottle	92013	Mayne Pharma International Pty Ltd	Medicine	A	11/26/2002

Health Canada Drug Approvals

View More Health Canada Approvals

Sign in to access additional Health Canada approved drug information with detailed regulatory data.

Approved Product	Company	DIN	Dosage Form	Strength	Market Date
MORPHINE EXTRA-FORTE	Pfizer Canada Ulc	00869325	Solution - Intramuscular , Intravenous , Subcutaneous	50 MG / ML	12/31/1990
MORPHINE SULFATE INJECTION EPIDURAL	Sterimax Inc	02498286	Solution - Epidural	1 MG / ML	6/2/2021
MORPHINE HP 50	Sandoz Canada, Inc.	00617288	Solution - Intramuscular , Intravenous , Subcutaneous	50 MG / ML	12/31/1987
MORPHINE SULFATE INJECTION	Jamp Pharma Corporation	02500701	Solution - Intravenous , Intramuscular , Subcutaneous	2 MG / ML	4/29/2021
MORPHINE SULFATE INJECTION	Jamp Pharma Corporation	02500728	Solution - Intramuscular , Subcutaneous , Intravenous	10 MG / ML	4/29/2021
MORPHINE SULFATE INJ 10MG/ML USP	Sandoz Canada, Inc.	00392588	Liquid - Subcutaneous , Intravenous , Intramuscular	10 MG / ML	12/31/1978
MORPHINE SULFATE INJECTION, USP	fresenius kabi canada ltd	02482738	Solution - Subcutaneous , Intravenous , Intramuscular	8 MG / 1 ML	N/A
M-ESLON	Ethypharm Inc	02019965	Capsule (Extended Release) - Oral	100 MG	12/31/1993
M.O.S. 10 SYRUP 10MG/ML	valeant canada lp / valeant canada s.e.c.	00632503	Syrup - Oral	10 MG / ML	12/31/1985
ORAMORPH SR TABLETS 100MG	roxane labs, division of boehringer ingelheim	01988743	Tablet (Extended-Release) - Oral	100 MG / TAB	12/31/1992

CIMA AEMPS Drug Approvals

View More CIMA AEMPS Approvals

Sign in to access additional CIMA AEMPS approved drug information with detailed regulatory data.

Approved Product	Company	Registration Number	Pharmaceutical Form	Prescription Type	Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

View More Philippines FDA Approvals

Sign in to access additional Philippines FDA approved drug information with detailed regulatory data.

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

View More Saudi SFDA Approvals

Sign in to access additional Saudi SFDA approved drug information with detailed regulatory data.

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

View More Malaysia NPRA Approvals

Sign in to access additional Malaysia NPRA approved drug information with detailed regulatory data.

Approved Product	Company	Registration Number	Dosage Form	Strength	Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

View More UK EMC Drug Information

Sign in to access additional UK EMC drug information with detailed pharmaceutical data.

Medicine Name	MA Holder	MA Number	Pharmaceutical Form	Active Ingredient	Authorization Date
No UK EMC drug information found for this drug.

Related News

Fentanyl Vaccine Shows Promise in Preclinical Studies, Faces Hurdles in Addiction Treatment

a year ago

A novel fentanyl vaccine has demonstrated promising results in rat models by blocking the drug's euphoric effects and reducing its impact on vital signs.

Lofexidine Trial Launched for Neonatal Opioid Withdrawal Syndrome

a year ago

Marshall University is conducting a clinical trial to assess oral lofexidine, a non-opioid medication, for treating Neonatal Opioid Withdrawal Syndrome (NOWS).

Exploring Non-Opioid Options for Chronic Pain Management

11 years ago

A review of studies highlights several non-opioid medications with potential benefits for chronic low back pain (CLBP), myofascial pain syndrome (MPS), and fibromyalgia (FM).